First-Episode Psychosis Management
On this page
Direct answer
A first psychotic episode is a therapeutic emergency in its own right: the duration of untreated psychosis (DUP) correlates with worse symptomatic and functional outcomes, so recognition and rapid engagement matter as much as drug choice. Treatment starts with a single second-generation antipsychotic at the lowest effective dose — risperidone 1-2 mg initially, titrated slowly — because first-episode patients respond at roughly half the doses used in chronic illness and are exquisitely sensitive to side-effects. Baseline weight, fasting glucose, lipids and ECG are recorded before the first tablet. Treatment resistance is not declared until two adequate antipsychotic trials (4-6 weeks each at adequate dose) have failed, and remission should be consolidated with 12-24 months of maintenance before any cautious, supervised taper is contemplated.
What you must remember
- DUP principle: shorter duration of untreated psychosis predicts better outcomes; the "critical period" for deterioration is the first 2-5 years after onset.
- Start low, go slow: first-episode patients need roughly half standard doses (risperidone 1-4 mg, olanzapine 5-10 mg); response assessment waits 4-6 weeks at an adequate dose.
- Baseline before the first dose: weight and waist, fasting glucose and lipids, blood pressure, ECG, and in relevant cases pregnancy testing and substance screen — a favourite structured viva answer.
- Clozapine is not a first-line drug: reserve for failure of two adequate trials; premature clozapine use in first-episode illness is an exam error.
- Duration of maintenance: at least 1-2 years after full remission in a first episode; every taper attempt carries substantial relapse risk (commonly quoted around 50-80% within months of stopping) and must be gradual and supervised.
- Psychosocial package: psychoeducation, family intervention targeting expressed emotion, CBT for psychosis, substance-use (especially cannabis) counselling, and early functional re-engagement — work or study, not waiting for "complete recovery".
- Indian context: under the District Mental Health Programme, first episodes often present late with long DUP; cannabis potency in street preparations has risen, and cannabis-associated psychosis in young men is a growing presentation in Indian OPDs.
The first two years, step by step
Begin with a 22-year-old engineering student brought by family after a week of auditory hallucinations and referential ideas, cannabis positive on screen. Acute phase (weeks 0-6): engage without confrontation, admit only if risk or self-care demands it, start risperidone 1 mg at night increasing to 2-3 mg, treat the cannabis use as a parallel target, and complete the baseline metabolic panel. The family receives structured psychoeducation including the relapse-signature — the patient's own early warning pattern of sleeplessness and social withdrawal.
Stabilisation (months 2-12): once symptoms settle, the priorities invert toward recovery — graded return to studies, CBT for residual delusional distress, family sessions to lower criticism and over-involvement, and honest discussion of the maintenance timeline. Consolidation (months 12-24): if fully remitted and functioning, some guidelines support a slow, monitored dose reduction with a pre-agreed relapse plan; in India, where follow-up is irregular and medication access may lapse, the clinician weighs the very real risk of silent discontinuation when planning any taper. Relapse is handled as information, not failure — search for the cause (adherence, substance use, stressor) and restart effective treatment early.
Where students slip
Three recurring slips: escalating dose rapidly in week one when the patient is merely sedated rather than responding; declaring "treatment-resistant schizophrenia" after one partial trial — the definition demands two adequate trials of 4-6 weeks each before the word resistance is used, and only then does clozapine enter; and counselling permanent treatment after a single episode, when guidelines actually support time-limited maintenance with a planned review. The exam also likes the differential buried in first-episode stems — autoimmune encephalitis in a patient with seizures and dyskinesias, or steroid-induced psychosis — before accepting schizophrenia.
Frequently asked questions
What is duration of untreated psychosis and why does it matter?
DUP is the time from onset of frank psychotic symptoms to start of adequate treatment; longer DUP is consistently associated with poorer symptomatic and functional outcomes.
At what doses are antipsychotics started in first-episode psychosis?
Roughly half of standard chronic-illness doses — for example risperidone 1-2 mg initially — because first-episode patients are more responsive and more side-effect sensitive.
When can treatment-resistant schizophrenia be diagnosed in a first episode?
Only after two adequate antipsychotic trials (appropriate dose for 4-6 weeks each, with adherence confirmed) have failed, at which point clozapine becomes the indicated drug.
How long should antipsychotics be continued after a first episode with full remission?
At least 12-24 months, with any subsequent taper gradual and closely supervised because early discontinuation carries a high relapse risk.
Which psychosocial interventions are core in first-episode care?
Psychoeducation, family intervention to reduce expressed emotion, CBT for psychosis, substance-use counselling and early vocational reintegration.